#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13890	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2222	623.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1479	1479	C	824	C	760	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25082	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3637	687.7	0	.	n	.	0	T695C	SNP	695	695	T	1111	1111	C	728	C,G	685,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25082	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3637	687.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1753	1753	A	818	A	762	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25082	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3637	687.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2387	2387	C	806	C,T	730,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25082	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3637	687.7	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3013	3013	T	793	T,C	747,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25082	23S	2890	2890	99.86	23S.l6.c30.ctg.1	3637	687.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2461	2461	A	801	A	755	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	V36A	NONSYN	106	108	GTG	380	382	GCG	155;155;154	G;C;G	144;146;146	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	Q50R	NONSYN	148	150	CAG	422	424	CGG	147;147;148	C;G;G	142;141;141	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	S68L	NONSYN	202	204	TCG	476	478	TTG	136;137;137	T,C;T,C;G	120,1;127,1;129	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	A90V	NONSYN	268	270	GCG	542	544	GTT	140;137;136	G;T,C;T,G	127;120,1;121,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	I105V	NONSYN	313	315	ATT	587	589	GTT	167;167;164	G;T;T	154;150;152	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	N125T	NONSYN	373	375	AAT	647	649	ACC	183;184;181	A;C;C	168;171;170	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	R135C	NONSYN	403	405	CGT	677	679	TGT	171;171;168	T;G;T	156;157;152	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	K151E	NONSYN	451	453	AAA	725	727	GAA	138;138;136	G;A;A	132;131;129	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	T152N	NONSYN	454	456	ACC	728	730	AAC	135;136;135	A;A;C	129;129;128	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	A172T	NONSYN	514	516	GCG	788	790	ACA	140;140;139	A;C;A	133;132;132	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	A175E	NONSYN	523	525	GCG	797	799	GAA	138;142;144	G,A;A;A	131,1;135;137	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	E176T	NONSYN	526	528	GAA	800	802	ACC	145;147;147	A;C;C	136;138;139	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	I178V	NONSYN	532	534	ATC	806	808	GTC	146;145;144	G;T;C	137;136;137	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	I188T	NONSYN	562	564	ATA	836	838	ACG	142;145;143	A;C;G,T	129;134;132,1	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	P200N	NONSYN	598	600	CCC	872	874	AAC	136;137;136	A;A;C	129;129;130	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	F220L	NONSYN	658	660	TTT	932	934	TTG	144;145;146	T;T;G	135;137;137	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	A239T	NONSYN	715	717	GCA	989	991	ACC	126;125;128	A;C;C	115;115;117	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	N240D	NONSYN	718	720	AAT	992	994	GAC	129;132;133	G;A;C	119;120;122	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	E243A	NONSYN	727	729	GAA	1001	1003	GCG	145;144;143	G;C,T;G	131;117,1;132	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	0	.	p	.	0	S255A	NONSYN	763	765	TCC	1037	1039	GCT	136;138;138	G;C;T	133;132;132	.	.
folP.Neisseria_meningitidis_H44_76_v1_00541	folP.Neisseria_meningitidis_H44_76_v1_00541	1	1	539	1496	folP	858	858	91.61	folP.l15.c4.ctg.1	1558	95.5	1	SNP	p	R230S	1	.	.	688	690	AGC	962	964	AGC	146;144;144	A;G;C	138;137;136	folP.Neisseria_meningitidis_H44_76_v1_00541:1:1:R230S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4760	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3493	135.9	1	SNP	p	S91F	0	.	.	271	273	TCC	606	608	TCC	150;151;151	T;C;C	141;141;143	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4760	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3493	135.9	1	SNP	p	D95G	0	.	.	283	285	GAC	618	620	GAC	157;159;159	G;A;C	147;149;149	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4760	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3493	135.9	1	SNP	p	D95N	0	.	.	283	285	GAC	618	620	GAC	157;159;159	G;A;C	147;149;149	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1518	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1321	114.5	1	SNP	p	G45D	1	.	.	133	135	GAC	442	444	GAC	189;192;194	G;A;C	178;180;182	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	774	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	896	85.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4578	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2904	156.9	1	SNP	p	D86N	0	.	.	256	258	GAC	547	549	GAC	160;160;163	G;A;C	151;150;155	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4578	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2904	156.9	1	SNP	p	S87I	0	.	.	259	261	AGT	550	552	AGT	164;163;163	A;G;T	154;153;151	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4578	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2904	156.9	1	SNP	p	S87R	0	.	.	259	261	AGT	550	552	AGT	164;163;163	A;G;T	154;153;151	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4578	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2904	156.9	1	SNP	p	S87W	0	.	.	259	261	AGT	550	552	AGT	164;163;163	A;G;T	154;153;151	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	4578	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2904	156.9	1	SNP	p	S88P	0	.	.	262	264	TCC	553	555	TCC	160;160;160	T;C;C	150;151;152	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3720	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2756	134.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1625	1627	GGC	172;173;172	G;G;C	165;163;161	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3400	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2429	139.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1208	1210	GCA	197;195;194	G;C;A	178;178;180	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3400	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2429	139.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1211	1213	ATC	195;196;198	A;T;C	180;180;181	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3400	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2429	139.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1223	1225	GTG	205;205;208	G;T;G	187;185;189	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3400	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2429	139.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1223	1225	GTG	205;205;208	G;T;G	187;185;189	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3400	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2429	139.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1727	1729	ACC	180;179;180	A;C;C	160;163;165	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3400	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2429	139.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1781	1783	GCG	150;152;149	G;C;G	132;121;127	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3400	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2429	139.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1781	1783	GCG	150;152;149	G;C;G	132;121;127	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3400	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2429	139.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1904	1906	GGC	141;140;138	G;G;C	128;126;127	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3400	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2429	139.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1913	1915	GGC	139;138;136	G;G;C	126;120;119	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3400	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2429	139.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1931	1933	CCG	122;120;126	C,G;C,G;G,A	95,3;91,1;94,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5146	ponA	2397	2397	99.96	ponA.l6.c30.ctg.1	3175	161.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1752	1754	CTG	157;159;158	C;T;G,A	142;144;145,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2088	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1893	109.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	613	613	C	147	C	138	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	G38E	NONSYN	112	114	GGA	434	436	GAA	204;203;203	G;A;A	191;191;189	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	E48G	NONSYN	142	144	GAA	464	466	GGA	206;210;214	G;G;A	193;196;200	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	T87A	NONSYN	259	261	ACT	581	583	GCT	183;184;186	G;C;T	173;175;177	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	T89S	NONSYN	265	267	ACC	587	589	AGC	190;188;188	A;G;C	181;180;178	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	.	MULTIPLE	358	359	AA	679	680	CG	218;219	C;G	208;206	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	.	MULTIPLE	361	362	GA	682	684	CAG	217;216;211	C;A;G	203;203;199	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	N122K	NONSYN	364	366	AAC	686	688	AAA	211;212;212	A;A;A	200;202;202	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	K143E	NONSYN	427	429	AAA	749	751	GAA	201;201;204	G;A;A	192;194;195	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	V151A	NONSYN	451	453	GTA	773	775	GCA	201;204;205	G;C;A	190;194;196	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	N212D	NONSYN	634	636	AAT	956	958	GAT	197;197;200	G;A;T	187;186;190	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	D213G	NONSYN	637	639	GAT	959	961	GGT	198;197;194	G;G;T,G	189;187;181,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	I218M	NONSYN	652	654	ATA	974	976	ATG	178;178;176	A,T;T;G	172,1;171;170	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	T256A	NONSYN	766	768	ACA	1088	1090	GCA	156;157;157	G;C;A	148;150;152	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	W257T	NONSYN	769	771	TGG	1091	1093	ACG	157;156;156	A;C;G	148;152;152	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	R258G	NONSYN	772	774	CGT	1094	1096	GGG	156;155;156	G;G;G	150;149;149	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1097	1099	GTT	157;154;155	G;T;T	148;145;149	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	L279V	NONSYN	835	837	TTA	1157	1159	GTA	194;194;194	G,A;T;A	177,1;179;179	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1196	1198	ACT	203;202;205	A;C;T	190;192;194	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	H294D	NONSYN	880	882	CAT	1202	1204	GAT	199;197;198	G;A;T	189;186;187	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	0	.	p	.	0	Y298H	NONSYN	892	894	TAC	1214	1216	CAC	198;200;203	C;A;C	190;189;192	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	1	SNP	p	G120K	1	.	.	358	360	AAG	679	681	CGG	218;219;216	C;G;G	208;206;198	porB1b.WHO_Z_02266c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	1	SNP	p	A121D	1	.	.	361	363	GAC	682	685	CGC	217;211;206	C;G;C	203;199;195	porB1b.WHO_Z_02266c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	2386	porB1b	1047	1047	97.04	porB1b.l15.c17.ctg.1	1510	157.5	1	SNP	p	D121N	0	.	.	361	363	GAC	682	685	CGC	217;211;206	C;G;C	203;199;195	porB1b.WHO_Z_02266c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	9454	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4845	194.4	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1995	1997	CAT	235;234;236	C;A;T	212;211;213	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1048	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1060	98.1	1	SNP	p	V57M	1	.	.	169	171	ATG	524	526	ATG	224;223;224	A;T;G	215;213;213	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
